Which of the following statements about Churg‑Strauss syndrome is correct? a) The central nervous system is typically affected. b) Positive antineutrophil cytoplasmic antibodies (ANCA) are characteristic in cases with renal involvement. c) Peripheral neuropathy presents with a stocking‑glove distribution. d) Peripheral blood eosinophilia is 5%.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

The correct answer is b) Positive ANCA is characteristic in cases of renal involvement

Based on the most recent and highest quality evidence, ANCA positivity is strongly associated with renal involvement in Churg-Strauss syndrome (now called eosinophilic granulomatosis with polyangiitis, EGPA) 1.

Analysis of Each Statement:

a) CNS is typically affected - INCORRECT

The central nervous system is rarely affected in EGPA 1. While CNS involvement can occur (reported in 4-17% of cases across different cohorts), it is not a typical feature 1. The disease predominantly affects peripheral nerves, not the CNS 1.

b) Positive ANCA is characteristic in cases with renal involvement - CORRECT

This is the correct answer. The 2013 Chapel Hill Consensus Conference specifically incorporated the concept that ANCA positivity is associated with renal involvement in EGPA 1. Multiple high-quality studies confirm this association:

  • MPO-ANCA positivity is strongly associated with glomerulonephritis 1
  • ANCA-positive patients have a 5-fold higher risk of renal involvement (OR 5.097) compared to ANCA-negative patients 2
  • Renal disease occurs in 27-51% of ANCA-positive patients versus only 12-16% of ANCA-negative patients 1, 3, 4
  • ANCA positivity correlates with biopsy-proven vasculitis and necrotizing glomerulonephritis 3, 4

c) Peripheral neuropathy presents with stocking-glove distribution - INCORRECT

This is a critical pitfall to avoid. Peripheral neuropathy in EGPA presents as mononeuritis multiplex, NOT stocking-glove distribution 1. The pattern is:

  • Mononeuritis multiplex (asymmetric, multifocal nerve involvement)
  • Usually sensory but may cause motor deficits
  • Axonal damage pattern on nerve conduction studies
  • Occurs in 50-70% of patients 1

The stocking-glove pattern suggests a length-dependent polyneuropathy, which is not characteristic of EGPA vasculitis.

d) Peripheral blood eosinophilia is 5% - INCORRECT

This dramatically understates the eosinophilia in EGPA. Eosinophilia >10% or >1,500 cells/μL is observed in almost all patients 1. The 1990 ACR criteria specify eosinophilia >10% 1, and the 2022 ACR-EULAR criteria use a threshold of ≥1 × 10⁹/L 1. Eosinophilia of only 5% would be insufficient for diagnosis.

Key Clinical Pearls:

ANCA-positive versus ANCA-negative phenotypes differ significantly:

  • ANCA-positive (30-40% of patients): Higher risk of renal involvement, peripheral neuropathy, purpura, and biopsy-proven vasculitis 1, 2
  • ANCA-negative: More frequent cardiac involvement, pulmonary infiltrates, and generally worse overall survival 1, 2

Common pitfall: Don't confuse the peripheral neuropathy pattern in EGPA (mononeuritis multiplex) with diabetic or other metabolic neuropathies (stocking-glove distribution).

Related Questions

What is the recommended treatment for asthma associated with ANCA (anti-neutrophil cytoplasmic antibodies)-associated vasculitis?
In a patient with anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis and renal involvement, which of the following findings may be present?
Can ANCA (anti-neutrophil cytoplasmic antibody)-associated vasculitis have low serum complement C3 and C4, and what does the latest data show?
What is the recommended treatment regimen for Churg‑Strauss syndrome (eosinophilic granulomatosis with polyangiitis)?
What are the differences in clinical manifestations between granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg‑Strauss syndrome) regarding (a) general symptomatology, (b) gastrointestinal involvement, (c) peripheral nervous system involvement, (d) renal involvement (proteinuria and hematuria), and (e) cardiac involvement?
What are the typical clinical features and presentation of vestibular paroxysmia in adults?
What are the indications and evidence supporting vitamin K2 (menaquinone‑7) supplementation?
What diagnostic workup is recommended for a 35-year-old man with a three-month history of malaise?
What is the appropriate management for a patient presenting with urticaria and a fever of 38 °C?
What lorazepam dose should be given to a patient with a Withdrawal Assessment Scale (WAS) score of 22 for severe alcohol withdrawal?
In a patient with bandemia, no recent hospitalization, and currently on levofloxacin, should a broad-spectrum antibiotic be added?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.